Literature DB >> 1739078

Expression of differentiation antigens and growth-related genes in normal kidney, autosomal dominant polycystic kidney disease, and renal cell carcinoma.

R Klingel1, W Dippold, S Störkel, K H Meyer zum Büschenfelde, H Köhler.   

Abstract

Cellular differentiation and mRNA levels of genes involved in kidney growth were investigated in normal kidney cells, cyst-lining epithelial cells of polycystic kidney disease, and renal carcinoma cells (RCC). All cells comparatively studied exhibited an antigenic phenotype of proximal tubular cells as shown by the expression of a panel of brush border membrane enzymes and kidney-associated cell surface antigens. The epithelial developmental antigen Exo-1 was expressed in 50% to 80% of cyst-lining epithelia in polycystic kidney tissue and in 20% to 30% of polycystic kidney cells cultured in vitro. Normal kidney cells and RCC were negative under identical culture conditions. The expression of antigen Exo-1 is associated with hyperproliferation in an epithelial tissue compartment composed of cells which have not yet reached their terminal differentiation state. Increased amounts of mRNA of the growth factor receptor system of epidermal growth factor (EGF) receptor and its ligand transforming growth factor (TGF)-alpha were associated with the malignant phenotype of RCC. Increased expression of EGF receptor and TGF-alpha, although less prominent, were also observed in polycystic kidney cells compared with normal kidney cells. In conclusion, the expression of Exo-1 in cyst-lining epithelial cells of autosomal dominant polycystic kidney disease (ADPKD) and the altered regulation of TGF-alpha and EGF receptor in these cells contribute to the hypothesis that hyperproliferation is an underlying pathogenic mechanism of ADPKD.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1739078     DOI: 10.1016/s0272-6386(12)70198-1

Source DB:  PubMed          Journal:  Am J Kidney Dis        ISSN: 0272-6386            Impact factor:   8.860


  10 in total

Review 1.  Polycystic kidney disease--a truly pediatric problem.

Authors:  M R Ogborn
Journal:  Pediatr Nephrol       Date:  1994-12       Impact factor: 3.714

2.  Transforming growth factor alpha (TGF-alpha) and other targets of tumor necrosis factor-alpha converting enzyme (TACE) in murine polycystic kidney disease.

Authors:  Raghad Nemo; Noel Murcia; Katherine Macrae Dell
Journal:  Pediatr Res       Date:  2005-03-17       Impact factor: 3.756

3.  Immunolocalization of transforming growth factor alpha in normal human tissues.

Authors:  M E Christensen; S S Poulsen
Journal:  Histochem Cell Biol       Date:  1996-05       Impact factor: 4.304

4.  Polycystin-1, the PKD1 gene product, is in a complex containing E-cadherin and the catenins.

Authors:  Y Huan; J van Adelsberg
Journal:  J Clin Invest       Date:  1999-11       Impact factor: 14.808

5.  Activation of the MEK5/ERK5 cascade is responsible for biliary dysgenesis in a rat model of Caroli's disease.

Authors:  Yasunori Sato; Kenichi Harada; Kazuo Kizawa; Takahiro Sanzen; Shinichi Furubo; Mitsue Yasoshima; Satoru Ozaki; Masahiko Ishibashi; Yasuni Nakanuma
Journal:  Am J Pathol       Date:  2005-01       Impact factor: 4.307

6.  Bioinformatics Study Identified EGF as a Crucial Gene in Papillary Renal Cell Cancer.

Authors:  GenYi Qu; Hao Wang; Cheng Tang; Guang Yang; Yong Xu
Journal:  Dis Markers       Date:  2022-05-24       Impact factor: 3.464

7.  Urinary EGF Receptor Ligand Excretion in Patients with Autosomal Dominant Polycystic Kidney Disease and Response to Tolvaptan.

Authors:  Laura R Harskamp; Ron T Gansevoort; Wendy E Boertien; Wim van Oeveren; Gerwin E Engels; Harry van Goor; Esther Meijer
Journal:  Clin J Am Soc Nephrol       Date:  2015-07-31       Impact factor: 8.237

8.  Increased expression of EGFR and TGF-alpha in segmental renal dysplasia in duplex kidney.

Authors:  Valeria Solari; Hideki Shima; Prem Puri
Journal:  Pediatr Surg Int       Date:  2004-04-03       Impact factor: 1.827

Review 9.  Proliferative signaling by ERBB proteins and RAF/MEK/ERK effectors in polycystic kidney disease.

Authors:  Mitchell I Parker; Anna S Nikonova; Danlin Sun; Erica A Golemis
Journal:  Cell Signal       Date:  2019-12-09       Impact factor: 4.315

10.  PBRM1 loss in kidney cancer unbalances the proximal tubule master transcription factor hub to repress proximal tubule differentiation.

Authors:  Xiaorong Gu; Francis Enane; Rita Tohme; Caroline Schuerger; Tomas Radivoyevitch; Yvonne Parker; Eric Zuberi; Bartlomiej Przychodzen; Babal Kant Jha; Daniel Lindner; Brian Rini; Yogen Saunthararajah
Journal:  Cell Rep       Date:  2021-09-21       Impact factor: 9.423

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.